Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Hypertension and Sleep Disordered Breathing in Pediatrics

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Melodi Pirzada MD, Winthrop University Hospital
ClinicalTrials.gov Identifier:
NCT00990899
First received: October 6, 2009
Last updated: October 31, 2016
Last verified: October 2016

October 6, 2009
October 31, 2016
October 2008
July 2011   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00990899 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Hypertension and Sleep Disordered Breathing in Pediatrics
Hypertension and Sleep Disordered Breathing in Pediatrics
The primary objective is to determine the prevalence of sleep disordered breathing in children with primary hypertension or pre hypertension. The secondary objectives are to determine any association factors for children with primary hypertension or prehypertension to have sleep disordered breathing be it gender, age, body mass index (BMI), family history (hx) or ethnic group.
This is an exploratory, cross sectional study involving identification of the children of the age between 10 years and 17 years diagnosed with primary hypertension who have not been previously diagnosed and or treated for sleep disordered breathing with the revised pediatric sleep questionaire (PSQ) for sleep disordered breathing. The subjects that have shown interest will be mailed the informed consent/assent form to tbe reviewed. The consent/assent form will be handed to the child and all their questions and concerns will be answered in a comprehensible manner.
Observational
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample
children aged 10 to 17 years who have been diagnosed with primary hypertension
  • Hypertension
  • Obstructive Sleep Apnea
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
24
July 2011
July 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • aged 10 to 17 years old diagnosed with primary hypertension

Exclusion Criteria:

  • refused to participate in the study
  • children to secondary hypertension
  • previously diagnosed with sleep disordered breathing
Both
10 Years to 17 Years   (Child)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00990899
08025
Yes
Not Provided
Not Provided
Melodi Pirzada MD, Winthrop University Hospital
Melodi Pirzada MD
Not Provided
Principal Investigator: Melodi Pirzada, MD Winthrop University Hospital
Winthrop University Hospital
October 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP